Fig. 1From: Correlation between immune-related adverse events and prognosis in patients with various cancers treated with anti PD-1 antibodyKaplan-Meier survival curve of overall survival (OS) and progression free survival (PFS). OS and PFS following anti PD-1 antibody treatment in with irAE group(N = 115) and without irAE group (N = 165)Back to article page